Clinical trial
SOFIA-LTT Study: A Study of Intermittent Long Term Treatment With PEGASYS…
NCT00442572 · Hoffmann-La Roche, Industry · Completed
Key facts
| NCT number | NCT00442572 |
|---|---|
| Title | SOFIA-LTT Study: A Study of Intermittent Long Term Treatment With PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With HBeAg Negative Chronic Hepatitis B (CHB). |
| Official title | Stop Progression of Fibrosis by Administration of Intermittent Continuous Treatment With Peginterferon Alfa-2a. Open-label, Randomized Efficacy and Safety Clinical Trial of Intermittent Continuous Treatment With Peginterferon Alfa-2a (PEGASYS) in Patients With HBeAg Negative Hepatitis B Responding… |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hepatitis B, Chronic |
| Intervention type | Drug |
| Interventions | PEGASYS [peginterferon alfa-2a] |
| Enrollment | 21 |
| Start date | Jul 3, 2006 |
| Primary completion | Apr 23, 2012 |
| Completion | Apr 23, 2012 |
| First posted | Mar 2, 2007 |
| Last update posted | Apr 24, 2025 |
| Countries | Bulgaria |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: